Published in J Cardiovasc Electrophysiol on January 01, 2005
Effect of Balloon Cryoablation on Left Atrial Function (CRYO-LA) | NCT00821015
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Left atrial thickness under the catheter ablation lines in patients with paroxysmal atrial fibrillation: insights from 64-slice multidetector computed tomography. Heart Vessels (2012) 1.13
Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation. Am J Kidney Dis (2010) 1.12
Multi-modality imaging to assess left atrial size, anatomy and function. Heart (2007) 1.00
Measurements of the left atrium and pulmonary veins for analysis of reverse structural remodeling following cardiac ablation therapy. Comput Methods Programs Biomed (2014) 0.84
Centerline tracking for quantification of reverse structural remodeling of the pulmonary veins following cardiac ablation therapy. Acad Radiol (2012) 0.84
Evaluating the left atrium by magnetic resonance imaging. Europace (2008) 0.83
The effect of different treatment strategies on left atrial size in patients with lone paroxysmal atrial fibrillation-a prospective cohort study. J Interv Card Electrophysiol (2008) 0.81
Characterization of Pulmonary Vein Dimensions Using High-Definition 64-Slice Computed Tomography prior to Radiofrequency Catheter Ablation for Atrial Fibrillation. Cardiol Res Pract (2014) 0.78
Updating the evidence for the effect of radiofrequency catheter ablation on left atrial volume and function in patients with atrial fibrillation: a meta-analysis. JRSM Open (2014) 0.77
Pulmonary vein morphology by free-breathing whole heart magnetic resonance imaging at 3 Tesla versus breathhold multi-detector computed tomography. J Magn Reson Imaging (2012) 0.77
The use of cardiac magnetic resonance imaging in the diagnostic workup and treatment of atrial fibrillation. Cardiol Res Pract (2012) 0.76
Characterization of the dynamic function of the pulmonary veins before and after atrial fibrillation ablation using multi-detector computed tomographic images. Int J Cardiovasc Imaging (2010) 0.75
The Effect of Catheter Ablation on Left Atrial Size and Function for Patients with Atrial Fibrillation: An Updated Meta-Analysis. PLoS One (2015) 0.75
The Prognostic Scoring System Establishment and Validation for Chronic Atrial Fibrillation Patients Receiving Modified Cox-Maze IV and Concomitant Cardiac Surgery. PLoS One (2015) 0.75
Pulmonary Vein Remodeling Following Atrial Fibrillation Ablation: Implications For The Radiographic Diagnosis Of Pulmonary Vein Stenosis. J Atr Fibrillation (2016) 0.75
Applications of computed tomography and magnetic resonance imaging in percutaneous ablation therapy for atrial fibrillation. J Interv Card Electrophysiol (2009) 0.75
Role of magnetic resonance imaging in atrial fibrillation ablation. Curr Treat Options Cardiovasc Med (2014) 0.75
Reversal of pulmonary vein remodeling after catheter ablation of atrial fibrillation. J Geriatr Cardiol (2016) 0.75
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation (2005) 6.68
Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol (2009) 6.58
Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol (2009) 3.18
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J (2003) 3.06
Association between renal function, diastolic dysfunction, and postoperative atrial fibrillation following cardiac surgery. Circ J (2013) 2.70
Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1? Stroke (2012) 2.27
Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol (2007) 2.25
Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation (2003) 2.17
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Dabigatran and thrombin modulate electrophysiological characteristics of pulmonary vein and left atrium. Circ Arrhythm Electrophysiol (2012) 2.01
Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis. Int J Stroke (2014) 2.00
Lipid paradox in acute myocardial infarction-the association with 30-day in-hospital mortality. Crit Care Med (2015) 1.99
Evaluation of microalbuminuria after non-ionic radiocontrast medium exposure in patients undergoing coronary angiography. Int J Cardiol (2007) 1.91
Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol (2002) 1.87
CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol (2011) 1.77
Sinus node dysfunction in atrial fibrillation patients: the evidence of regional atrial substrate remodelling. Europace (2012) 1.75
Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation. Heart Rhythm (2012) 1.65
Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis. J Cardiovasc Electrophysiol (2011) 1.60
Paradoxical long-term proarrhythmic effects after ablating the "head station" ganglionated plexi of the vagal innervation to the heart. Heart Rhythm (2013) 1.59
Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes. Crit Care Med (2010) 1.57
Frequency analysis in different types of paroxysmal atrial fibrillation. J Am Coll Cardiol (2006) 1.56
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure. Int J Cardiol (2013) 1.56
Effects of aging and ouabain on left atrial arrhythmogenicity. J Cardiovasc Electrophysiol (2007) 1.55
Lung adenocarcinoma with ipsilateral breast metastasis: a simple coincidence? J Thorac Oncol (2013) 1.54
Electrophysiology of pulmonary veins. J Cardiovasc Electrophysiol (2006) 1.54
Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher. Europace (2012) 1.53
The different mechanisms between late and very late recurrences of atrial fibrillation in patients undergoing a repeated catheter ablation. J Cardiovasc Electrophysiol (2006) 1.53
Long-term outcome of catheter ablation in patients with atrial fibrillation originating from nonpulmonary vein ectopy. J Cardiovasc Electrophysiol (2012) 1.52
CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan. Int J Cardiol (2012) 1.51
Progressive remodeling of the atrial substrate--a novel finding from consecutive voltage mapping in patients with recurrence of atrial fibrillation after catheter ablation. J Cardiovasc Electrophysiol (2006) 1.49
Morphological changes of the left atrial appendage after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.47
Acute effect of circumferential pulmonary vein isolation on left atrial substrate. J Cardiovasc Electrophysiol (2009) 1.46
Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2005) 1.45
High-resolution mapping around the crista terminalis during typical atrial flutter: new insights into mechanisms. J Cardiovasc Electrophysiol (2004) 1.45
Validation of the frequency spectra obtained from the noncontact unipolar electrograms during atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.45
Heterogeneous expression of potassium currents and pacemaker currents potentially regulates arrhythmogenesis of pulmonary vein cardiomyocytes. J Cardiovasc Electrophysiol (2009) 1.45
Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation--the potential role beyond the CHA₂DS₂-VASc score. Heart Rhythm (2012) 1.44
Validation of a new index for estimating arterial stiffness: measurement of the QPV interval by Doppler ultrasound. Clin Cardiol (2006) 1.44
The beneficial effects of Tai Chi Chuan on blood pressure and lipid profile and anxiety status in a randomized controlled trial. J Altern Complement Med (2003) 1.43
A novel finding- impairment of gastric myoelectricity after catheter ablation of atrial fibrillation. Circ J (2013) 1.43
Impact of right-ventricular apical pacing on the optimal left-ventricular lead positions measured by phase analysis of SPECT myocardial perfusion imaging. Eur J Nucl Med Mol Imaging (2014) 1.43
Heart failure enhances arrhythmogenesis in pulmonary veins. Clin Exp Pharmacol Physiol (2011) 1.41
Significance of left circumflex artery-related acute myocardial infarction without ST-T changes. Am J Emerg Med (2010) 1.41
Relationship between arrhythmogenic pulmonary veins and the surrounding atrial substrate in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2010) 1.41
Effect of Feedback Signal on Blood Pressure Self-regulation Capability in Individuals With Prehypertension or Stage I Hypertension: A Randomized Controlled Study. J Cardiovasc Nurs (2016) 1.40
Usefulness of time interval between end of diastolic mitral annular velocity pattern and onset of QRS for predicting left ventricular end-diastolic pressure. Am J Cardiol (2006) 1.39
Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation - An ENGAGE AF-TIMI 48 Subanalysis. Circ J (2016) 1.39
A prospective, randomized comparison of modified pulmonary vein isolation versus conventional pulmonary vein isolation in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2012) 1.39
Unusual phenomenon of spontaneous termination of atrioventricular nodal reentrant tachycardia with 2:1 atrioventricular block. J Cardiovasc Electrophysiol (2003) 1.39
Paradoxical aging changes of the atrioventricular nodal properties in patients with atrioventricular nodal re-entrant tachycardia. Circ J (2011) 1.39
Heat-stress responses modulate beta-adrenergic agonist and angiotensin II effects on the arrhythmogenesis of pulmonary vein cardiomyocytes. J Cardiovasc Electrophysiol (2011) 1.39
Noncontact three-dimensional mapping guides catheter ablation of difficult atrioventricular nodal reentrant tachycardia. Int J Cardiol (2006) 1.39
Mechanism of adenosine-induced termination of focal atrial tachycardia. J Cardiovasc Electrophysiol (2004) 1.38
Dietary supplementation and engaging in physical activity as predictors of coronary artery disease among middle-aged women. J Clin Nurs (2013) 1.38
Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: the effect of meteorological factors. Heart Rhythm (2013) 1.38
Frequency and risk factors associated with atherosclerotic plaques in patients with a zero coronary artery calcium score. J Chin Med Assoc (2011) 1.38